Tumor Suppressors Status in Cancer Cell Line Encyclopedia

被引:22
作者
Sonkin, Dmitriy [1 ]
Hassan, Mehedi [1 ]
Murphy, Denis J. [1 ]
Tatarinova, Tatiana V. [1 ,2 ]
机构
[1] Univ South Wales, Pontypridd CF37 1DL, M Glam, Wales
[2] Univ So Calif, Lab Appl Pharmacokinet, Los Angeles, CA 90089 USA
关键词
Tumor suppressor; Cancer cell line; CCLE; Loss of function; DNA methylation; Epigenetics; DATABASE; GENE; MDM2; MUTATION; PATHWAY; SAMPLES; TP53;
D O I
10.1016/j.molonc.2013.04.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor suppressors play a major role in the etiology of human cancer, and typically achieve a tumor-promoting effect upon complete functional inactivation. Bi-allelic inactivation of tumor suppressors may occur through genetic mechanisms (such as loss of function mutation, copy number (CN) loss, or loss of heterozygosity (LOH)), epigenetic mechanisms (such as promoter methylation or histone modification), or a combination of the two. We report systematically derived status of 69 known or putative tumor suppressors, across 799 samples of the Cancer Cell Line Encyclopedia. In order to generate such resource we constructed a novel comprehensive computational framework for the assessment of tumor suppressor functional "status". This approach utilizes several orthogonal genomic data types, including mutation data, copy number, LOH and expression. Through correlation with additional data types (compound sensitivity and gene set activity) we show that this integrative method provides a more accurate assessment of tumor suppressor status than can be inferred by expression, copy number, or mutation alone. This approach has the potential for a more realistic assessment of tumor suppressor genes for both basic and translational oncology research. (C) 2013 Federation. of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:791 / 798
页数:8
相关论文
共 26 条
[1]   MutaDATABASE: a centralized and standardized DNA variation database [J].
Bale, Sherri ;
Devisscher, Martijn ;
Van Criekinge, Wim ;
Rehm, Heidi L. ;
Decouttere, Frederik ;
Nussbaum, Robert ;
Den Dunnen, Johan T. ;
Willems, Patrick .
NATURE BIOTECHNOLOGY, 2011, 29 (02) :117-118
[2]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[3]   Signal transduction pathway profiling of individual tumor samples [J].
Breslin, T ;
Krogh, M ;
Peterson, C ;
Troein, C .
BMC BIOINFORMATICS, 2005, 6 (1)
[4]   Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin [J].
Efeyan, Alejo ;
Ortega-Molina, Ana ;
Velasco-Miguel, Susana ;
Herranz, Daniel ;
Vassilev, Lyubomir T. ;
Serrano, Manuel .
CANCER RESEARCH, 2007, 67 (15) :7350-7357
[5]   PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro [J].
Finn, Richard S. ;
Dering, Judy ;
Conklin, Dylan ;
Kalous, Ondrej ;
Cohen, David J. ;
Desai, Amrita J. ;
Ginther, Charles ;
Atefi, Mohammad ;
Chen, Isan ;
Fowst, Camilla ;
Los, Gerret ;
Slamon, Dennis J. .
BREAST CANCER RESEARCH, 2009, 11 (05)
[6]   The APC gene in colorectal cancer [J].
Fodde, R .
EUROPEAN JOURNAL OF CANCER, 2002, 38 (07) :867-871
[7]   Towards precise classification of cancers based on robust gene functional expression profiles [J].
Guo, Z ;
Zhang, TW ;
Li, X ;
Wang, Q ;
Xu, JZ ;
Yu, H ;
Zhu, J ;
Wang, HY ;
Wang, CG ;
Topol, EJ ;
Wang, Q ;
Rao, SQ .
BMC BIOINFORMATICS, 2005, 6 (1)
[8]   X-chromosome inactivation in mammals [J].
Heard, E ;
Clerc, P ;
Avner, P .
ANNUAL REVIEW OF GENETICS, 1997, 31 :571-610
[9]   Genome-wide in situ exon capture for selective resequencing [J].
Hodges, Emily ;
Xuan, Zhenyu ;
Balija, Vivekanand ;
Kramer, Melissa ;
Molla, Michael N. ;
Smith, Steven W. ;
Middle, Christina M. ;
Rodesch, Matthew J. ;
Albert, Thomas J. ;
Hannon, Gregory J. ;
McCombie, W. Richard .
NATURE GENETICS, 2007, 39 (12) :1522-1527
[10]   Massively regulated genes: the example of TP53 [J].
Hollstein, Monica ;
Hainaut, Pierre .
JOURNAL OF PATHOLOGY, 2010, 220 (02) :164-173